iSpecimen Inc reports results for the quarter ended in March - Earnings Summary

iSpecimen

07/05/2024 14:53

* iSpecimen Inc  ISPC.OQ  reported a quarterly adjusted loss
of 32
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -27
cents.  The lone analyst forecast for the quarter was for a loss
of 27 cents per share. 
    * Revenue fell 22.4% to $2.29 million from a year ago;
analysts
expected $2.84 million. 
    * iSpecimen Inc's reported EPS for the quarter was a loss
of 32
cents​.
    * The company reported a quarterly loss of $2.9 million.
    * iSpecimen Inc shares had risen by 19.1% this quarter and
lost 44.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 22.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "buy"

Wall Street's median 12-month price target for iSpecimen Inc is
$3.00 
This summary was machine generated from LSEG data May 7 at 01:53
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.27          -0.32          Missed
 Dec. 31 2023      -0.24          -0.32          Missed
 Sep. 30 2023      -0.35          -0.23          Beat
 Jun. 30 2023      -0.30          -0.39          Missed